1. Home
  2. RPTX

as 06-20-2025 3:41pm EST

$
-
.
-
-
-
$
-
.
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.

Founded: 2016 Country:
Canada
Canada
Employees: N/A City: SAINT-LAURENT
Market Cap: 63.9M IPO Year: 2020
Target Price: $4.50 AVG Volume (30 days): 92.3K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.01 EPS Growth: N/A
52 Week Low/High: $0.89 - $4.29 Next Earning Date: 08-05-2025
Revenue: $1,073,000 Revenue Growth: -98.90%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

RPTX Daily Stock ML Predictions

Share on Social Networks: